Mediar Therapeutics

Today marks a very special milestone at Mediar Therapeutics: Our first employee and CSO leader, Paul Yaworsky, PhD, is celebrating his 5th year! 🎊 Paul, your scientific acumen, unwavering dedication, and infectious enthusiasm have been paramount to Mediar’s ability to advance a novel fibrosis portfolio into the clinic.    You inspire us to go above and beyond to realize our mission for patient impact in the treatment of #fibrosis.     Here’s to many more years of success! #TeamAnniversaries #WorkMilestones #EmployeeAppreciation #CompanyCulture #biotech

Cheers to Timothy Kiprono and Jeffrey Bornstein, MD who are celebrating their anniversaries with Mediar! Your passion and expertise have made a remarkable impact on our workplace and our mission to pioneer a new path in #fibrosis treatment.    Looking forward to many years to come! #CompanyCulture #biotech

Welcome Thendral Selvam, our Summer Co-Op graduate student majoring in biotechnology at Northeastern University. Fun fact:  Thendral is a foodie who loves cooking – noting she finds it a relaxing and delicious way to express her creativity – as well as exploring different restaurants and cafes. We’re excited to have you on board for an enriching, immersive experience in #biotech. #fibrosis #CompanyCulture

We’re back from our Summer shutdown and energized with some exciting updates! Congratulations to Gabby Dower, PhD, Aashna Gupta, SHRM-CP, Ben Wilks, PhD, Morgan Fetherolf, PhD and Chelsea Duncan on your recent promotions! Thank you all for being part of our stellar team! #fibrosis #CompanyCulture #biotech

Summer is (finally) here, and Mediarites are looking forward to fun in the sun and our week-long summer shutdown. ☀🌴 It’s time to wind down, relax and rejuvenate with family and friends. Wishing you a safe and healthy Fourth of July! #CompanyCulture #fibrosis #biotech

Big congratulations to Mediarite Morgan Fetherolf, PhD, Senior Scientist, for winning our Q2 Living the Values Award! 🎊   Throughout this past quarter, Morgan has exemplified our core values of curiosity, integrity, and community. He tackles challenges with an infectious smile and unwavering determination. His strong work ethic and genuine concern for those around him are truly inspiring. Keep on rockin’, Morgan!   #CompanyCulture #biotech #fibrosis

Our latest Shooting Star award goes to Hyesung Sin! 📣 As executive assistant to our leadership team, Hyesung always goes above and beyond and plays a vital role in our success. Thank you for helping ensure flawless operations, Hyesung! 🌟 #CompanyCulture #gratitude #fibrosis #biotech

Our Chief Scientific Officer Paul Yaworsky, PhD, is off to Copenhagen for The Extracellular Matrix Pharmacology Congress, where his two presentations will encompass targeting the myofibroblast for novel anti-fibrotic therapies and findings for Anti-WISP1 (MTX-463) as a novel potential therapy for idiopathic pulmonary #fibrosis. We’re eager to contribute to the conversation about target discovery and drug development across fibro-inflammatory diseases. Dive deeper here: https://lnkd.in/emQkxec4 #biotech #ECM2024

Cheers to a dynamic duo of 🌟 Shooting Star Award winners 🌟 Saroj Nepal, PhD, and Max Leabo – essential members of our science team. We are grateful for your contributions to our scientific achievements, including IND-enabling studies and advancement to the clinic. Continue to shine bright! #fibrosis #companyculture #biotech

Today we celebrate another Mediarite milestone: Happy one-year anniversary to Rohan Manohar, PhD, Director of Clinical Translational Medicine! 🎊 Over the past year, Rohan has proven himself to be an invaluable member of our team, bringing his dedication, scientific prowess, and passion to advance our mission to deliver novel therapies for fibrotic diseases. Thank you, Rohan! #CompanyCulture #Fibrosis